Who
Shelley Chu
Director
Company insider
Files Form 4 as: Director, Odyssey Therapeutics; Director, HilleVax.
In numbers
- Trades disclosed
- 7
- Buys
- 1
- Sells
- 0
- Bought
- $400K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 19 Aug 2022
- Last trade
- 11 May 2026
- Last filed
- 11 May 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 11 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $200K11,111 at $18.00 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $200K11,111 at $18.00 | filing |
| 17 Sep 2025filed 17 Sep 2025 | HilleVax | SEC FORM 4 Code U | —17,199 | filing |
| 23 Jun 2025filed 25 Jun 2025 | HilleVax | SEC FORM 4 Code A | —17,199 at $0.00 | filing |
| 6 Jun 2024filed 30 Apr 2025 | HilleVaxoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | HilleVaxoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 19 Aug 2022filed 23 Aug 2022 | HilleVaxoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026ODTX · manilatimes.net · 6 Oct 2026
0 headlines in the last 90 days name Shelley Chu; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.